First Command Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27M Buy
2,465
+130
+6% +$132K 0.02% 59
2025
Q4
$2.51M Buy
2,335
+951
+69% +$909K 0.02% 56
2025
Q3
$1.06M Sell
1,384
-226
-14% -$168K 0.01% 87
2025
Q2
$1.26M Sell
1,610
-461
-22% -$358K 0.01% 70
2025
Q1
$1.71M Buy
2,071
+78
+4% +$64.9K 0.02% 52
2024
Q4
$1.54M Sell
1,993
-33
-2% -$27.3K 0.01% 56
2024
Q3
$1.79M Buy
2,026
+1
+0% +$899 0.02% 53
2024
Q2
$1.83M Buy
2,025
+83
+4% +$66.4K 0.02% 41
2024
Q1
$1.51M Buy
1,942
+572
+42% +$407K 0.02% 46
2023
Q4
$799K Buy
1,370
+15
+1% +$8.76K 0.01% 71
2023
Q3
$728K Buy
+1,355
New +$698K 0.01% 70

Other funds holding LLY

First Command Advisory Services's LLY Position: Q1 2026 in Review

First Command Advisory Services increased its Eli Lilly (LLY) stake by 5.6% in Q1 2026, buying an estimated $132K and bringing the position to 2,465 shares worth $2.27M. The position accounts for 0.02% of the portfolio, ranked #59.

First Command Advisory Services first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.51M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First Command Advisory Services held 2,465 shares of Eli Lilly worth $2.27M as of Q1 2026.
  • First Command Advisory Services bought 130 Eli Lilly shares in Q1 2026, an estimated $132K.
  • Eli Lilly made up 0.02% of First Command Advisory Services's portfolio in Q1 2026, its #59 holding.
  • First Command Advisory Services first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • First Command Advisory Services's Eli Lilly position peaked at $2.51M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First Command Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.